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ABSTRACT
Background. The mental health stigma of pharmacists, the most accessible health
professional, can have a significant impact on not only how these patient’s seek
treatment, but also their quality of life (Mey et al., 2013). This study intends to explore
mental health stigma among pharmacists and also examine the need for continuing
education focused on mental health.
Methods. This study was a descriptive cross-sectional study that employed a selfadministered online survey. The subjects were pharmacist members of the Mississippi
Pharmacists Association (MPhA). Demographic characteristics were collected. The level
of mental health stigma among the respondents was examined using the Community
Attitudes Toward the Mentally Ill (CAMI) scale in its full 40-question format. Social
desirability bias that was evaluated using a validated 13 question revision of the MarlowCrowne Social Desirability scale. The final variable measured was the interest in mentalhealth specific continuing education. Descriptive statistics were employed to meet study
objectives.
Results. Caucasian females practicing in Mississippi composed the majority of
respondents with an average age of 51 and an average of 26 years of practice. Most
respondents considered their geographic location to be urban and their primary practice
setting as an independent community pharmacy at which they were employed full-time.
In relation to their personal experience with mental illness, the majority reported having
at the least observed someone they believed had a mental illness in passing or on
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television. The results of the CAMI scale indicated that, on average, the pharmacists
disagreed with the concepts of the authoritarianism and social restrictiveness subscales
and agreed with those of the benevolence subscale. The average for the CMHI subscale
was approximately in the mid-range and did not indicate agreement or disagreement.
Respondents indicated a variety of continuing education needs related to mental illness.
Conclusion. Pharmacists generally indicated low levels of stigma with regard to
mental illness, however, they indicate a need for continuing education in a variety of
treatment areas. Continuing education providers are encouraged to provide programming
not only for mental illness treatment, but also for navigated the care of such patients.
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INTRODUCTION
Mental Illness and Its Presence in Society
According to the National Alliance on Mental Illness (NAMI), one in every 5 US
adults lived with a mental illness in 2018. 1 in every 25 of these adults suffered
specifically from a severe mental illness (“Mental Illness,” 2019). Mental illness can be
generally defined as a health condition that directly affects one’s emotions, mental
processes or behavior and can greatly affect one’s functioning in every aspect of life
(“Mental Health Conditions”). In the United States today, half of adults will experience
some form of mental illness at any given point in their life (Kapil, 2019). With
adolescents, ages 13 to 18, having the highest prevalence at a staggering 49.5% and a
quarter of young adults aged 18 to 25 living with a mental illness, the increasing number
of diagnoses could foreshadow a much larger presence of mental illness in the everyday
lives of citizens in years to come (“Mental Illness,” 2019). Currently, 1 in every 8 visits
to the emergency room is due to some form of mental illness or substance abuse (“Mental
Health by…,” 2019). Not only does mental illness cause an increase of almost a billion
dollars globally per year for hospitals due to relapses, the impact can be felt across all
sectors of the economy (Rüsch et al., 2005). The estimated economic cost of mental
illness within the next 20 years is projected to be at least $16 trillion dollars and expected
to be more. In the United States alone, $100-$170 billion dollars will be lost in annual
income to those struggling with mental illnesses (“Mental Health by…,” 2019). Mental
illness has also been ranked among the top 10 most costly illnesses to U.S. employers due
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to employee absences and lower productivity (Davlasheridze et al., 2018). With numbers
drastically increasing, mental illness could potentially become a much larger concern as
younger generations reach adulthood.
Despite the growing numbers of individuals diagnosed with mental illness
annually, there is a deficit of mental health services available in the United States.
According to NAMI, nationally only 43% of adults living with a mental illness within the
United States received treatment in 2018. The average delay between the first
developments of a mental health condition and receiving treatment is 11 years and many
times patients either do not continue treatment or don’t adhere correctly to their
respective therapies (“Mental Health by…,” 2019).
Although quite a few medications are available and behavioral therapies have
been developed, there are multiple reasons as to why patients may not receive treatment
for mental health conditions. Firstly, the cost of receiving mental health treatment has
caused a huge barrier for multiple reasons. In 2018, massive budget cuts were made
related to the treatment of mental health disorders including a $400 million-dollar budget
cut for mental health and substance abuse programs and $6.2 billion dollars in funding to
housing programs (Sperling, 2017). Additionally, many insurance companies have
reduced spending on mental health services, forcing patients to pay millions of dollars in
out-of-pocket costs (Winerman, 2017) A gap in the availability of health care
professionals has caused more expenses for patients as well, forcing patients to drive long
distances just to receive treatment (Wood et al., 2018). Due to the shortage of resources,
many of those who are in desperate need of treatment have to turn to services that are not
fit to give them the resources they need. Despite these efforts to change the focus of the
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Department of Mental Health to more widespread community-based facilities rather than
state mental hospitals, there was a $14 million cut to the budget of the Department of
Mental Health just a year later (Smith, 2017). Another major barrier to patients seeking
treatment is the existence of mental health stigma.
Beginning in approximately 700-480 B.C., the idea of stigma was presented as a
method of labeling criminals and slaves. Those with mental illnesses were often included
in this label and suffered years of torture being categorized as criminals. Entering the
Middle Ages, this stigma translated into the assumption that developing such illnesses
was somehow a punishment from God and meant one was evil or possessed, leading to
more murder and torture until the Enlightenment period (Cressman, 2014).
Although there was less of a presence for a short period of time, mental health
stigma again came to light in the 1940s with the introduction of sterilization. (Rossler,
2016). In modern-day culture, the concept of mental illness and what the term entails is
greatly influenced by media outlets. In Kalpana Srivastava’s article “Media and Mental
Illness,” he states that “mass media not only reflect public attitudes and values but also
take a part in shaping them.” With the dramatized, flawed and exploited representation of
mental illness in the media shaping the public’s definition, many view individuals with
such illnesses in a derogatory way. Such social isolation and exclusion have led to an
increased stigma toward those living with mental illnesses. Use of stereotypes, prejudice,
and discrimination to create an “us” compared to “them” narrative has gradually led to
the idea of “self-stigma” that has caused a large portion of patients to either decline
treatment or stop it early on to avoid the discrimination associated with it (Rüsch et al.,
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2005). Mental health stigma can be seen everywhere, but one concerning aspect of
mental health stigma is its existence among healthcare professionals.
Mental Health Stigma Among Healthcare Professionals
The World Health Organization (WHO) defines health professionals as those
who, “… play a central and critical role in improving access and quality health care for
the population. They provide essential services that promote health, prevent diseases and
deliver health care services to individuals, families and communities based on the
primary health care approach.” Frequent interactions with those with mental illnesses
allow health professionals to be a major resource for help and treatment, but stigma has
been reported to have a negative effect on the potential of this treatment.
Mental health stigma among healthcare professionals can be defined as a negative
demeanor toward patients due to bias or prejudice and is in response to apparent signs of
a mental illness based on a personal or stereotypical viewpoint (Black et al., 2009). The
presence of this stigma is speculated to be due to a “culture” within the healthcare
community that influences the perception of those with mental illnesses and their
importance compared to those with other forms of illnesses (Knaak et al., 2017).
Patients have reported feeling ignored and treated as though they are less-thanhuman by their healthcare professionals. Due to this expectation, many are hesitant to
seek treatment. When they do, many times it is of lesser quality due to the strained
relationship between provider and patient and can also present some safety concerns
(Knaak et al., 2017). Research shows the effects of stigma on the availability and quality
of treatment towards those with mental illnesses along with many reporting that it has an
impact on self-esteem and social interactions in both personal and business affairs as well
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(D’Arrigo, 2017). Stigma also is correlated with a lack of personnel trained and pursuing
work in the field (Alfredsson et al., 2017). Among those professionals that do pursue a
career related to mental health, many report a feeling of under-preparedness and stress
that ultimately leads to a level of uneasiness when approached by a patient with a mental
illness (Knaak et al., 2017). Within every team of healthcare professionals involved in the
treatment plan for each patient, the pharmacists play an important role in influencing the
outcome of each treatment plan and the level of comfort the patient experiences.
Mental Health Stigma Among Pharmacists
Pharmacists are the most available mental health professionals and also the
professional that patients see most frequently (Mey et al., 2013). The Journal of
American Pharmacists Association presented multiple studies showing that mental health
stigma among pharmacists has contributed to a negative impact on patients’ self-image
and social interactions (D’Arrigo, 2017). This stigma can lead to pharmacists being
discriminatory and affect the quality of care for those with mental illnesses in the
pharmacy setting (Giannetti et al., 2018).
The development of mental health stigma could be attributed to a number of
influences including inexperience in the field, lack of exposure and knowledge, and a
personal bias toward individuals with mental illnesses. These influences effect how
pharmacists interact in the workplace with those with mental illnesses (Alfredsson et al.,
2017, Giannetti et al., 2018). Those with no experience in mental health actually express
the most stigma according to a study conducted by Vincent Gianetti (Giannetti et al.,
2018). The drastic impact that stigma has had on the well-being of those with mental
illnesses can easily be seen in the extent of stigma along pharmacists alone. Negative
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attitudes toward individuals with mental illnesses among pharmacists can be correlated
with less effective, lower quality treatment and a greater number of relapses (Alfredsson
et al., 2017). Pharmacists have the potential to be a very important presence within the
mental health community with the ability to influence the adherence and attitudes of
patients toward medication treatment (Bell et al., 2006)(Murphy et al., 2016). With half
of the patients on antipsychotic medications failing to fully adhere to the presented plan
of treatment, pharmacists could play a large role in encouraging patients by developing
ways to help patients feel more comfortable and confident with their understanding and
motivation to adhere to medication regimens (Rüsch et al., 2005). Additional studies
show that some mental health patients report being comfortable but felt as though there is
a lack of medication monitoring and consideration (Caley & Stimmel, 2012).
Dr. Emily Black, in her article titled “Community Pharmacist Services for People
with Mental Illnesses: Preferences, Satisfaction, and Stigma,” presents the idea that
patients reporting feeling comfortable may be unaware of services that could be provided
but are not due to the presence of mental health stigma (Black et al., 2009). With future
generations presenting growing numbers of patients presenting with signs of mental
illness, decreasing this stigma among pharmacists could be a large step toward providing
higher quality health care services and increasing adherence to medication therapy in the
future.
Along with improving the services currently offered, pharmacists have the
potential to offer additional services to patients with mental illnesses. They could have
the opportunity to work alongside other providers in contributing their knowledge of side
effects, drug interactions, dosage and cost information when creating medication therapy
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ffor patients (Kinast et al., 2015). Also, pharmacists may play a role in offering additional
services, such as depression screenings, and referring patients toward resources and
services of other professionals (Gammage & Emberley, 2015).
Mental Health Stigma Among Pharmacists – Literature Review
As mentioned previously, mental health stigma among pharmacists can lead to
poorer quality of care for individuals living with mental illness and may be a contributing
factor to why patients do not receive adequate treatment. Although multiple studies show
that pharmacists seem to express positive attitudes, they do report being uncomfortable in
a close and more intimate setting such as counseling (Watkins et al., 2017). Pharmacists
report other factors contributing to their inability to provide adequate treatment including
time restraints and a lack of privacy. Another major contributor to pharmacists’ hesitation
in approaching the treatment of patients with mental illness is a lack of knowledge.
Overall, pharmacists report a lack of knowledge of mental health not only in the
United States but in other countries including the United Kingdom (Murphy et al., 2014).
Some studies, in contrast, show that pharmacists do feel as though their education was
sufficient, but their level of comfort with counseling and discussing symptoms with those
patients was not (Goodman et al., 2017). Some articles presented the idea of mental
health literacy being an avenue of decreasing mental health stigma among pharmacists by
increasing the level of knowledge and confidence speaking with patients regarding
mental illness.
Mental health literacy can be defined as “the knowledge and beliefs about mental
disorders which aid in their recognition, management and prevention” (Oreilly et al.,
2010). One study expressed that pharmacists who scored higher in their level of mental
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health literacy were more to conduct medication counseling or offer care. (Oreilly et al.,
2015). With the main concern reported being communication skills, many scientists
began to conduct studies and research different approaches to offering mental health
education to pharmacists (Bell et al., 2006).
In recent years, programs have risen to help lower the mental health stigma
among healthcare professions. A study conducted in 2016 surveyed 32 pharmacists after
attending a continuing education (CE) program containing consumer-led sessions
allowing face-to-face interaction with patients with mental illnesses. Although there were
changes in attitudes and social distancing immediately after the interventions, the results
were not maintained long-term (Rickles & Dacosta, 2016). Along with other consumerled programs, many private organizations have initiated programs to improve mental
health literacy and decrease mental health stigma. Mental Health First Aid (MHFA),
established in 2001, developed a set of classes to help develop participants’ abilities to
“identify, understand and respond” to situations involving those with mental illnesses
(“About,” 2013).This program is not only available for healthcare professionals but also
anyone who would like to increase their understanding of mental illness. A 2018 study
conducted 18 trials with a total of 5,936 participants and concluded that the classes are
effective in making small changes in the level of stigma, knowledge and recognition up
to 6-months post-training, but any long-term progress is unclear (Morgan et al., 2018).
A similar program, More than Meds, hosts courses on improving, specifically
pharmacists’, level of comfort and understanding of those with mental illness along with
the face-to-face sessions with patients, similar to that seen in the Rickles study (Murphy,
2014). Although the program has been developed and used for other purposes, there is a
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concern with how to determine the effectiveness of the research in relation to pharmacist
attitudes and how well results are replicated (Murphy et al., 2014).
In light of the existing literature related to mental health stigma among pharmacy
professionals discussed, this study intends to expand upon the literature examining
mental health stigma in not only health professionals as a whole but specifically
pharmacists. With a lack of literature documenting the interest of pharmacists in CE
related to mental illness, this study intends to introduce this to the literature and provide a
basis for further studies.
Study Objectives
In light of the literature available studying pharmacists’ experiences with patients with
mental illness, the objectives of this study are to:
1. Measure Mississippi pharmacists’ experience with mental illness.
2. Measure Mississippi pharmacists’ perceived level of stigma associated with
mental illness.
3. Determine if pharmacy experience, mental illness education or mental illness
work experience is related to pharmacists’ perceived level of stigma associated
with mental illness.
4. Measure Mississippi pharmacists’ experiences with, and desire for, continuing
education related to mental illness.
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METHODS
Design
The study conducted was an electronic, self-administered, voluntary, anonymous
survey of pharmacists who were members of the MPhA. It was exempted by the
University of Mississippi’s Institutional Review Board on December 9, 2019 prior to the
study being conducted. The study was a descriptive cross-sectional study that was
conducted at one time with no specific experimental design.
Sample
The study sample included pharmacists who are members of the MPhA. The
response rate was unable to be obtained due to a transition in leadership immediately
after release of the survey to pharmacists.
Data Collection
The data was collected using the Qualtrics survey software and was distributed in
an email giving a brief description of the study objectives and an anonymous link to the
survey via the MPhA listserv. The email was sent to pharmacists on February 18, 2020,
and data collection continued for one month. After all data was collected, SPSS v.26 was
used for any statistical analyses.
Measures
Demographic variables. The demographic characteristics considered in this study
included age, gender, ethnicity, state of residence and geographic location.
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Data was also collected regarding the participants’ years of pharmacy experience,
employment status, the setting of their primary practice and if they have ever worked in a
setting that specialized in mental health.
Experience with Mental Illness. In addition, a question was included to determine
the participants’ level of general experience with mental illness by providing a range of
circumstances with different intensities and allowing for all that applied to be marked.
Mental Health Stigma. To assess each pharmacist’s level of stigma toward
patients with mental illnesses, the CAMI Scale was used in its entirety of 40 statements.
The purpose of utilizing the CAMI scale was to apply a scale that was originally intended
for a public or community setting to professionals to analyze the general stigma of each
individual rather than to tailor the scale to solely survey mental health stigma in the
pharmacy setting. The CAMI scale was used in its original format. The items were scored
using a 5-point Likert scale with options ranging from “strongly agree” to “strongly
disagree.” The 40 items were used to assess each participants level of authoritarianism,
benevolence, social restrictiveness and community mental health ideology and are evenly
split with 10 items per facet. The authoritarianism subscale focuses on determining
respondents’ attitudes toward hospitalization of the mentally ill, their differences from
what is perceived as “normal,” custodial care, and causes of mental illness (Taylor &
Dear, 2017). The benevolence subscale focuses on respondents’ attitudes toward
society’s responsibility for the mentally ill, the attitude one should have toward those
individuals, willingness to be involved with them, and anticustodial feelings (Taylor &
Dear, 2017). The third subscale titled “social restrictiveness” measures the respondents’
stance toward dangerousness of the mentally ill, distancing themselves from them
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socially, prevention of responsibility, and the normality of those individuals (Taylor &
Dear, 2017). The fourth and final subscale entitled “community mental health ideology”
determines attitudes toward the value of community for therapeutic purposes, the effect
the presence of mental health facilities has on a geographic area, the danger posed to
residents living in that area, and deinstitutionalized care (Taylor & Dear, 2017).
For each subscale analyzed, there were 5 “pro” statements and 5 “anti” statements
that were dispersed throughout the survey. “Pro” statements are those that indicate a
positive attitude toward the concepts related to that subscale while “anti” statement
indicates a negative attitude toward those concepts (Taylor & Dear, 2017). All
statements are labeled in Table 4 for each subscale using the appropriate superscript to
indicate which set they are from. Negative statements were recorded in the dataset before
analysis. Each subscale also has an overall mean and standard deviation separate from the
individual items. The overall means are determined by averaging the responses of all
items and is a number between 10 and 50. In comparison, the mean for each item is found
by averaging individual responses from participants and is a number between 1 and 5.
Social Desirability Bias. Social desirability bias was measured to account for
CAMI responses that might have been desirable responses as opposed to truthful
responses, a bias phenomenon that often occurs in social and behavioral research. Social
desirability bias was assessed using a validated 13-statement revision of the MarloweCrowne Social Desirability Scale (Reynolds, 1982). The scale consists of statements with
a true-false response format that are to be answered based on if they apply to the
participant. This revision was used in place of the original in an effort to lower the
amount of time required to complete the survey and increase the likelihood of a larger
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number of responses. Each respondents’ social desirability score was calculated by giving
each statement a value of 0 or 1 dependent on each participants response. By finding the
value of each statement for all participants, a social desirability score ranging from 0 to
13 was calculated. A higher social desirability score indicates a higher likelihood that a
respondent answered in a way that they believed would be culturally favorable or is
indicative of more social desirability bias. Table 1 indicated how respondents’ responses
are scored.

TABLE 1
Social Desirability Scale and Response Values

It is sometimes hard for me to go on with my work if I am
not encouraged.
I sometimes feel resentful when I don't get my way.
On a few occasions, I have given up doing something
because I thought too little of my ability.
There have been times when I felt like rebelling against
people in authority even though I knew they were right.
No matter who I'm talking to, I am always good listener.
There have been occasions when I took advantage of
someone.
I'm always willing to admit when I make a mistake.
I sometimes try to get even rather than forgive and forget.
I am always courteous, even to people who are
disagreeable.
I have never been irked when people expressed ideas very
different from my own.
There have been times when I was quite jealous of the
good fortune of others.
I am sometimes irritated by people who ask favors of me.
I have never deliberately said something that hurt
someone's feelings.
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True

False

0

1

0

1

0

1

0

1

1

0

0

1

1

0

0

1

1

0

1

0

0

1

0

1

1

0

Continuing Education Interest. The survey concluded with 3 questions pertaining
to the participants’ amount of continuing education related to mental health along with
whether there was an interest in the opportunity. There was also a free-response question
to allow participants to give topics that interested them in relation to mental health and
those they would like to see in continuing education courses.
Analysis
Frequencies and means were used to present demographic variables. Frequencies
were calculated to assess objective 1 (measuring pharmacists’ experience with mental
illness). For objective 2 (measuring pharmacists’ level of stigma associated with mental
illness), reliability of the CAMI scale was assessed using Cronbach’s alpha. The scale
mean and per-item means were also calculated. For objective 3 (determining if pharmacy
experience, mental illness education or mental illness work experience is related to
pharmacists’ perceived level of stigma associated with mental illness), analysis including
correlations and independent samples t-tests. Significant differences, if any, were
detected at p < 0.05. For objective 4 (measuring pharmacists’ experiences with, and
desire for, continuing education related to mental illness), frequencies were calculated.
To analyze the qualitative data associated with this research objective, 3 independent
investigators individually categorized responses into themes. After independently
identifying themes, the investigators met to come to consensus on themes and resolve any
disagreement in categorizations. Data was presented in a summated way by presenting
and discussing example quotes for each theme.
In addition, a post-hoc analysis was conducted to determine if years of pharmacy
experience or previous experience with a mental health specific work setting were related
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to level of stigma associated with mental illness. An individual analysis for each subscale
of the CAMI scale was conducted to determine the relationship between each and years
of experience. To determine if mental illness education or mental illness work experience
is related to pharmacists’ perceived level of stigma associated with mental illness,
independent-sample t-tests were conducted.
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RESULTS
Response Rate
In total, there were 95 respondents that completed at least a portion of the survey.
22 were missing responses for 25% or more of the stigma scale, resulting in 73 complete
responses that were able used to be used in the final data analysis. The response rate
could not be calculated due to a transition in management within the MPhA which
resulted in the inability to retrieve the total number of pharmacists’ whom received an
invitation for participation.
Demographic Characteristics
Several demographic questions were included at the beginning of the survey to
determine the diversity of the respondents for use in the discussion of the data analysis.
Table 2 below summarizes the raw number value and frequencies of each item for all
demographic characteristics excluding age and years of practice. For age and years of
practice, averages were found to be approximately 51 years old and 26 years of practice
in the pharmacy profession.
For the final demographic characteristic determined, labeled “Primary Practice
Setting” in Table 2, 8 options were given along with an “Other” option to allow
respondents to describe their primary practice setting if not listed. 9 (12.2%) selected the
“Other” option and indicated that they would describe their primary practice settings as
medical affairs, poison control, industry, compounding, regulatory, and consultant.
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TABLE 2
Demographic Data of Survey Respondents
Characteristics
Gender
Women
Men
Race/Ethnicity
White/Caucasian
Asian/ Asian Indian
African American/Black
Hispanic
American Indian/Alaska Native
Other
State of Residence
Mississippi
Arkansas
Tennessee
Michigan
Ohio
Geographic Location
Urban
Rural
Unanswered
Employment Status
Full-time
Part-time
Unemployed
Primary Practice Setting
Independent Community Pharmacy
Chain Community Pharmacy
Hospital/Institutional Pharmacy
Other
Long-Term Care
Academia
Ambulatory Care
Specialty Pharmacy

No. Respondents (%)
40 (54.1)
34 (45.9)
67 (90.5)
4 (5.4)
3 (4.1)
0
0
0
63 (85.1)
1 (1.35)
1 (1.35)
1 (1.35)
1 (1.35)
41 (55.4)
32 (43.2)
1 (1.35)
44 (59.5)
24 (32.4)
6 (8.1)
23 (31.1)
18 (24.3)
12 (16.2)
9 (12.2)
6 (8.1)
3 (4.1)
3 (4.1)
0

Objective 1 Results
The first objective of this study was to measure the amount of experience the
sample of pharmacists had with mental illness. Pharmacists were asked to mark all
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statements that applied to themselves in regard to their personal experience with mental
illness with each consecutive statement increasing in severity. Table 3 presents the results
of each statement. Out of all 11 possible responses, the 2 that most of the pharmacists felt
applied to their personal experience with mental illness were that they had “observed, in
passing, a person I believe may have had a severe mental illness” and had “watched a
movie or television show in which a character depicted a person with mental illness.”

TABLE 3
Mental Illness Familiarity

I have never observed a person that I was aware had a
severe mental illness.
I have observed, in passing, a person I believe may have
had a severe mental illness.
I have watched a movie or television show in which a
character depicted a person with mental illness.
I have watched a documentary on the television about
severe mental illness.
I have observed persons with a severe mental illness on a
frequent basis.
My job includes providing services to persons with a
severe mental illness.
My job involves providing services/treatment for persons
with a severe mental illness.
A friend of the family has a severe mental illness.
I have a relative who has a severe mental illness.
I live with a person who has a mental illness.
I have a severe mental illness.

Severity

Frequency

1

2

2

55

3

55

4

34

5

25

7

26

8

35

9
10
11
12

23
28
3
0

In addition to the Mental Illness Familiarity survey, a question was included
following the table to determine the percentage of pharmacists that had experience
working in a mental health-specific setting. Of the total sample population of
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pharmacists, 19 (25.7%) indicated that they had, while 55 (74.3%) pharmacists indicated
they had not.

FIGURE 1
Respondents’ Experience in a Mental-Health Specific Setting

Yes

No

Objective 2 Results
The second objective of this study was to measure the sample of pharmacists’
level of stigma associated with mental illness. The data from the CAMI scale collected
during survey distribution was used through SPSS v.26 to determine the Cronbach’s
alpha, mean and standard deviation for each of the 4 subscales. The mean and standard
deviation were also determined for each item.
On average, the respondents had low overall scores on the authoritarianism
subscale, indicating a disagreement with its core concepts. They also scored relatively
19

low for the social restrictiveness subscale and therefore disagree with its associated ideas.
Respondents, on average, agreed with the concepts at the base of the benevolence
subscale with a large mean score, but averaged in the middle of the scale for the CMHI
subscale.

TABLE 4
Results of CAMI Scale Statistical Analysis
No. of
Items

𝛼

Mean

SD

Authoritarianism subscalea,d
As soon as a person shows signs of mental
disturbance, he should be hospitalized.b
Mental illness is an illness like any other.c
There is something about the mentally ill
that makes it easy to tell them from normal
people.b
Less emphasis should be placed on
protecting the public from the mentally ill.c
Mental patients need the same kind of
control and discipline as a young child.b
The mentally ill should not be treated as
outcasts of society.c
The best way to handle the mentally ill is to
keep them behind locked doors.b
Mental hospitals are an outdated means of
treating the mentally ill.c
One of the main causes of mental illness is a
lack of self-discipline and will power.b
Virtually anyone can become mentally ill.c

10

0.61

21.56

3.94

1.96

0.70

2.07

0.99

2.11

0.92

3.01

0.84

2.58

0.88

1.81

1

1.55

0.67

3.14

0.93

1.63

0.72

1.71

0.61

Benevolence subscalea,d
More tax money should be spent on the care
and treatment of the mentally ill.b
The mentally ill are a burden on society.c
The mentally ill have for too long been the
subject of ridicule.b
Increased spending on mental health
services is a waste of tax dollars.c

10

40.85

4

4.07

0.88

3.73

0.99

4.30

0.54

4.20

0.71

Item

20

0.69

We need to adopt a far more tolerant
attitude toward the mentally ill in our
society.b
There are sufficient existing services for the
mentally ill.c
Our mental hospitals seem more like prisons
than like places where the mentally ill can
be cared for.b
The mentally ill do not deserve our
sympathy.c
We have the responsibility to provide the
best care for the mentally ill.b
It is best to avoid anyone who has mental
problems.c
Social Restrictiveness subscalea,d
The mentally ill should be isolated from the
rest of the community.b
The mentally ill are far less of a danger than
most people suppose.c
A woman would be foolish to marry a man
who has suffered from mental illness, even
though he seems fully recovered.b
No one has the right to exclude the mentally
ill from their neighbourhood.c
I would not want to live next door to
someone who has been mentally ill.b
Mental patients should be encouraged to
assume the responsibilities of normal life.c
Anyone with a history of mental problems
should be excluded from taking public
office.b
The mentally ill should not be denied their
individual rights.c
The mentally ill should not be given any
responsibility.b
Most women who were once patients in a
mental hospital can be trusted as baby
sitters.c
Community Mental Health Ideology
subscalea,d
The best therapy for many mental patients is
to be part of a normal community.b
Locating mental health facilities in a
residential area downgrades the
neighborhood.c
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10

10

0.77

0.89

3.94

0.86

4.14

0.83

3.42

0.98

4.48

0.65

4.30

0.64

4.27

0.58

23.68

5.02

1.82

0.69

2.74

0.91

2.25

0.83

2.34

1.02

2.60

0.92

2.22

0.77

2.44

0.94

2.15

1.21

1.88

0.50

3.26

0.83

34.78

6.10

3.78

0.71

3.37

1

As far as possible mental health services
should be provided through communitybased facilities.b
Having mental patients living within
residential neighborhoods might be good
therapy, but the risks to residents are too
great.c
Residents should accept the location of
mental health facilities in their
neighbourhood to serve the needs of the
local community.b
Local residents have good reason to resist
the location of mental health services in
their neighbourhood.c
Locating mental health services in
residential neighbourhoods does not
endanger local residents.b
Mental health facilities should be kept out of
residential neighbourhoods.c
Residents have nothing to fear from people
coming into their neighborhood to obtain
mental health services.b
It is frightening to think of people with
mental problems living in residential
neighborhoods.c

4.01

0.66

3.52

0.85

3.25

0.89

3.40

0.94

3.30

0.86

3.30

0.83

3.22

0.95

3.64

0.81

a Measured on a 5-point scale where 5 = Strongly Agree and 1 = Strongly Disagree
b “Pro” statements
c “Anti” statements – these statements were recoded before analysis
d Overall means are out of 50.

Objective 3 Results
The third objective of this study was to determine if pharmacy experience, mental
illness education or mental illness work experience is related to pharmacists’ perceived
level of stigma associated with mental illness.
Years in practice was significantly and positively correlated with
Authoritarianism (r = 0.358; p = .003) and Social Restrictiveness (r = 0.446; p = .000)
and was significantly and negative correlated with Benevolence (r = -0.250; p = .039) and
Community Mental Health Ideology (r = -0.330; p = 006).
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When comparing pharmacists that had taken no continuing education in mental
illness versus those that have, there were no differences in CAMI scores for any of the 4
domains. When comparing pharmacists that had work experience in a setting that
specialized in mental illness to pharmacists that did have experience in a setting
specializing in mental illness, there were again, no difference in CAMI scores for any of
the 4 domains.
Objective 4 Results
The fourth and final objective of this study was to determine the desire and need
for continuing education related to mental health or mental illnesses along with what
specifically pharmacists desired to be educated on. The first question of this threequestion series was if the respondents had ever taken any continuing education related to
mental health previously. The results of this question can be found in Figure 2, in which
42 (56.8%) reported that they had while 32 (43.2%) reported that they had not.

FIGURE 2
Respondents’ Experience with Mental Health Related CE
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Yes

No

The second question assessed whether there was an interest in continuing
education focused on mental health. Presented in Figure 3, 63 (85.1%) pharmacists
reported that they were interested while 11 (14.9%) were not interested.

FIGURE 3
Respondents’ Interest in Continuing Education Related to Mental Health

Yes
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No

The third and final question of the series gave the pharmacists who reported that
they were interested in mental health continuing education an opportunity to present
topics they would like discussed. Among the responses, there were a few categories that
many respondents shared interest in. Firstly, many pharmacists were interested in
education on specific conditions such as substance abuse, addiction, attention deficit
disorder (ADD), bipolar disorder, depression, anxiety, obsessive-compulsive disorder
(OCD), dementia, post-traumatic stress disorder (PTSD) and schizophrenia. Other
pharmacists indicated interest in being educated on topics related to the broader spectrum
of mental illnesses such as the specific types that exist, updates on medications for mental
health as a whole, causes of mental illness and treatments that are available. A third
category that emerged is an interest in continuing education focused on more specific
topics related to mental health such as the mental health of new mothers with post-partum
depression, the use of antipsychotics for patients with dementia and ketamine for
depression, teenage mental health, medication compliance specifically in mental health
patients, dispensing medication to those with substance abuse or alcoholism, and mental
health-related concerns in those with dementia or Alzheimer’s living in long-term care
facilities. The final category that many pharmacists were interested in was the general
treatment of those living with mental illnesses. This category included an interest in what
it is like living with a mental illness, how to properly approach a situation involving
psychotic patients, understanding the needs of mental health patients and how best to
assist them, treatment of those living with co-morbid mental illnesses, denial of benefits
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that is associated with such disorders, the effect of counseling, and ultimately how to
encourage the acceptance of those living with mental illnesses.

26

DISCUSSION
For the authoritarianism subscale, the “pro” statements had an encouragingly low
mean of 1.97, and the “anti” statements also had a low mean of 2.3 (where 1 = strongly
disagree and 5 = strongly agree). Although it seems that respondents displayed a strong
agreement with viewing mental health patients as normal people in comparison to those
with other illnesses, other statements suggested that respondents did not fully agree that
mental health patients were “normal.” The statement stating the need for control and
discipline had a mean of 2.58, indicating that responses averaged close to neutral rather
than disagreeing. In addition, the statement that patients should not be treated as outcasts
received a surprising low mean of 1.81, seeming to indicate agreement with viewing
mental health patients as outsiders. Respondents did express disagreement with
hospitalization and the view that mental illness can be caused by controllable
circumstances.
With the benevolence subscale having a mean of 40.85 out of possible total score
of 50, respondents overall agreed with the concepts that influenced the statements of the
subscale. The “anti” statements had a high mean of 4.16, but the “pro” statements also
had a high mean of 4.00, indicating that their responses were not as polarized as they
seemed. The statements indicating the beliefs that tax dollars are wasted on mental health
services, that mental health patients deserve no sympathy, and that they should be
avoided received surprisingly high means of 4.2, 4.48, and 4.27. Agreement with these
signifies the presence of mental health stigma in their views of how one’s attitude should
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be toward those with mental illness and societies involvement with them. Additionally,
they did agree that more tax money should be spent on treatment and that we have the
responsibility to provide care which could indicate some indecisiveness about the
responsibilities of society.
Respondents, based on the overall average, disagreed with the fundamental
concepts underlying the third subscale of social restrictiveness including levels of danger
patients impose, need for social distancing, preventing responsibility from being placed
with patients, and the normality of patients. Based on the individual means for each item,
the sample group seemed to express positive attitudes toward patients with mental illness
in relation to social restrictiveness subscale with no strong indication of mental health
stigma related to it. There were 2 statements, though, had surprising responses. With a
mean of 2.22, respondents mostly disagreed with encouraging mental health patients to
assume the responsibilities of normal life. They also mostly disagreed that they should
not be denied their rights, indicating that there is a low level of stigma potentially present.
For the community mental health ideology subscale, the overall mean averaged
toward the middle of spectrum with the largest standard deviation of all the subscales at
6.10. In comparison between the “pro” and “anti” statements, respondents averaged
similar responses for both. Some statements that received higher averages than expected
were those stating that locating mental health facilities downgrade the area, having these
facilities poses a risk to residents and that resisting the placement of these facilities in
neighborhoods is in good reason. Based on the results of all subscales presented, it could
be said that the sample group of pharmacists did not display a strong presence of mental
health stigma.
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The Marlowe-Crowe Social Desirability Scale, as presented in Table 1, has a
score range of 1 to 13. The mean score of all respondents was found to be 7.65, indicating
that it is likely that their responses to the CAMI scale portion of the survey may not have
been highly influenced by a concern with social acceptance.
Studies also using the CAMI scale can be found determining stigma levels of
health professionals other than pharmacists. A study of 64 respondents found that mental
health professionals, including the Department of Youth Services staff, reported
disagreeing more strongly with the authoritarianism and social restrictiveness subscales
with means of 19.6 and 17.3 compared to the means of 21.56 and 23.68 found for
pharmacists in this study. They also reported agreeing more strongly with the
benevolence and CMHI subscales with means of 42.8 and 38.8 compared to the means of
40.85 and 34.78 found for pharmacists (Browne, 2010). This comparison could indicate a
larger presence of stigma in pharmacists when compared to mental health professionals.
Another study examining the mental health stigma of nursing students with a sample
group of 90 indicates that the nurses scored similarly to the pharmacists in this study for
the social restrictiveness and CMHI subscales with means of 23.60 and 34.94, but agreed
more with the authoritarianism subscale (M=23.27) and less with benevolence subscale
(M=38.49) (Morrison, 2011). This could suggest a higher presence of stigma found in
nurses compared to pharmacists.
A surprising result from the demographic portion of the survey was the lack of
respondents indicating that they had a mental illness. With statistics from 2018 finding
that not only did one in every 25 have a serious mental illness, but that 1 in every 5 had
any mental illness, it came as a surprise that no respondents reported having a mental
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illness (“Mental Illness,” 2019). Another surprising result, from the continuing education
portion of the survey, was that more pharmacists had previously taken a continuing
education course related to mental health than had not. Although this was originally
unexpected, this could potentially have been related to the lower level of stigma found
when interpreting the CAMI scale results. An interesting result additionally came from
the final question allowing pharmacists to report what they would be interested in being
educated on while taking a CE course focused on mental health. The expectation when
including that addition to the survey was that a few respondents would choose to respond
but there was actually a large response rate reporting a wide range of interests. It would
be interesting to see the impact implementing these results would have on attendance and
impact of CE courses focused on mental health.
For the question used to determine respondents’ level of personal experience with
mental illness, multiple of the frequencies could be explained or expected. Considering
the statistic presented previously about the frequency of mental illness in the United
States, it is not surprising that only 2 pharmacists out of the 74 respondents reported
having never encountered someone with a mental illness. Although it seems that it would
be difficult to say that one has never encountered someone at all with a mental illness,
this result could suggest that mental illness is not as obvious as previously perceived. The
frequency of those who reported having seen someone in passing or on a television show
or movie was much higher than those of the other statements, supporting the idea
previously mentioned that media plays a large role in defining mental illness for the
majority of Americans today. Another result that could be anticipated was that
approximately half of the respondents reporting that they provide treatment and services
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for those with mental illness. This could be referencing many different aspects of the
everyday workflow of pharmacists nationally including distributing and counseling
patients on their medications, medication adherence programs and even additional
services in more specialized settings. The final result of objective to consider is the
indication that the majority of respondents worked in a retail setting but not many of the
have worked in a mental-health specific setting. With the majority of pharmacies in the
United States being chain and independent retail pharmacies, the career opportunities are
much more accessible compared to pharmacies in a mental-health specific setting.
Some results of the CAMI scale portion of the survey came at a surprise while
others could have been expected. First, based on the responses for multiple questions
regarding how “normal” those with mental illnesses are, one could say that the
respondents were conflicted on their views about this. With defining “normal” being
strongly influenced by subjective and societal perceptions, each person defines the term
“normal” differently with that definition being quite dynamic and ever-changing which
could explain the confliction in regard to these statements. Additionally, the results
indicated that the majority of pharmacists believed that patients with mental illnesses
should be viewed as outcasts that do not deserve sympathy. Further research may be
needed to clarify this finding. The statements regarding hospitalization and the cause of
mental illness being controllable, in contrast, had polarizing results toward disagreement.
This result may have been a function of their medical education that contributed to their
levels of empathy toward patients with mental illness. Another set of statements whose
results should be considered were those focused around the distribution of tax dollars and
their role in aiding those with mental illnesses. Responses suggested that pharmacists
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were also conflicted about this topic. As previously mentioned, mental illness is costly to
employers and has a large impact on the economy which could have influenced their
responses to those statements. It could also be related to the current political climate with
the distribution of tax dollars being a sensitive topic for the upcoming presidential
election. Also, there was slight indication that patients with mental illness should be
restricted in their levels of responsibilities and rights. This could have also been due to
the media influence on how those with mental illnesses are viewed, which is mostly an
exaggerated and inaccurate picture of the reality of mental illness. Finally, the
respondents were conflicted about whether mental health facilities should be allowed in
residential areas. The media showing those with mental illnesses as violent or unstable
could have contributed to this and caused respondents to consider the safety of the
residents of the neighborhoods.
When comparing CAMI scores among pharmacists with differing years of
experience, mental illness education, and mental illness work experience, the amount of
continuing education they completed with regard to mental illness or the amount of
experience that had working at a mental illness facility did not seem to impact CAMI
scores. Our evaluation of pharmacist’s continuing education or work experience with
regard to illness were very basic “yes-no” questions, so further evaluation may be needed
to draw conclusions over the possible impact of continuing education and work
experience. However, when correlating overall years of total work experience with
CAMI scores, it was found that more years of work experience as a pharmacist
significantly and positively related to Authoritarianism and Social Restrictiveness and
negatively and significantly related to Benevolence and Community Mental Health
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Ideology. While this finding needs more exploration, it may lead to the question as to
whether pharmacists develop more negative perceptions of the mentally ill the longer
they are in practice.
For objective 4, determining the need and desire for continuing education, many
responses resulted in both expected and unexpected results. When originally considering
the need for continuing education specific to mental illness, it was projected that more
respondents than not had not taken a similar course. The findings, however, show that
more pharmacists had actually taken a course like this at some point in their pharmacy
practice. This may be related to the lower levels of stigma revealed from the CAMI scale
results. The majority of pharmacists, although most had taken a course previously,
surprisingly expressed interest in mental health-specific continuing education. With
multiple pharmacists indicating interest in understanding how to handle situations
involving mental health patients and how to best assist them, the respondents’ lack of
comfort may have been an influence in this result. Education on specific disorders was
another topic that reappeared repeatedly in the results of objective 4 and proposed a
surprising interest in not mental health in general but understanding each individual
disorder. This interest could also be influenced by the respondents’ lack of comfort and
search for understanding not only the social aspect but the biological aspects of mental
health as well. Although the sample group of pharmacists were not surveyed on their
opinion in the quality of mental health education they received during their college
career, the request for broader spectrum topics that focus on basic knowledge about
mental illness could be an indication of their confidence in the knowledge. This result
was observed in similar studies and was not a completely unexpected results (CITE).

33

Based on the results of the CAMI scale analysis, it can be said that the sample
group did not express a high level of mental health stigma but did report not feeling
confident in their knowledge of a variety of topics. Similar results were presented in a
study in which pharmacists showed interest in offering mental health patients counseling
and additional services to aid in improving their quality of treatment but felt that they
lacked the knowledge and confidence to do so (Giannetti et al., 2018). As a respondent in
Watkins’ study said, “the health care profession needs sensitivity training that recognizes
mental health issues as a disease just as acceptable as diabetes, hypertension and other
common disease” (Watkins et al., 2017). This could potentially increase the level of
comfort pharmacists have with personal interactions with mental health patients by
making them aware of the way their personal beliefs effect their behaviors in such
situations. It could also improve the patients’ outlook on themselves and their condition
(Knaak et al., 2017).
To begin the discussion of the steps needed to offer these courses, a few concerns
must be taken into consideration. First, the cost of continuing education could play a
large role in promoting an incentive to take these continuing education courses. With
many employees incurring out of pocket costs for their CE courses, the cost may be
playing a larger role in their choices than the content. According to the Publication 535 of
the IRS, employers have the opportunity to write off any expense concurred to reimburse
employees for their CE on their taxes as a portion of their business expenses. Previously,
out-of-pocket costs could be written off on the employees’ personal taxes as work-related
expenses with the addition of a Schedule A form to include itemized deductions if their
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employer decided against reimbursement, but as of 2017 W-2 employees are no longer
able to do so (United States). Grants to cover the expenses of such classes could be
another avenue for offering a course to a larger group of pharmacists. Non-profit
organizations such the Community Pharmacy Foundation have funded grants in the past
for courses such as the Mental Health First Aid program but currently do not offer grants
specifically to fund continuing education unless part of a larger grant project. Another
obstacle to encouraging the attendance of mental health CE courses is encouraging
attendance when other options are available. According to the Mississippi Board of
Pharmacy, pharmacists are required to complete 15 hours of CE for 2020, with 5 hours
dedicated to opioid abuse and at least 2 to a live seminar. (“Continuing Education
Requirements,” 2018). Finding a way for courses such as MHFA to count toward those
hours could provide incentive. Another option for increasing the likelihood of
pharmacists being interested is potentially offering courses online that allow pharmacists
to fit such an intensive course into their already busy schedules.
The most important discussion to be had in regard to this study is its application
to society, specifically the impact it could have to better pharmacists’ understanding and
level of comfort with mental illness and how this will improve the quality of treatment
mental health patients receive universally. With pharmacists mostly reporting a lack of
comfort in not only this study but also previous studies, mental health CE could offer the
training needed to help fill the gaps of knowledge and understanding needed for
participants to feel more comfortable. As Dr. Nathanial Rickles, a professor of pharmacy
practice explained, gaps could include a lack of training on how to screen patients, how
to offer supportive interventions and the education needed to be able to offer referrals for
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additional treatment, which are not typical of pharmacy curriculums (Rickles, 2018). This
could present the opportunity to offer additional services such as the implementation of
multidisciplinary health care teams and depression screenings. Although pharmacies
offering depression screenings is still currently being researched and tested, such a
service could offer a simple and cost-effective way to decrease the amount of mental
health patients living without the treatment they need and decrease the difference of the
number of services available in comparison to those with chronic illnesses such as
diabetes and hypertension (Rubio-Valera et al., 2014).
Limitations
When considering the results of this study, some limitations arose that could
affect the application of this project to larger sample populations. With approximately 91
percent of the sample group identifying as Caucasian and 85 percent practicing in
Mississippi, the lack of ethnic and geographical diversity limits the applications of this
study to a larger population. Additionally, the small sample size could also affect the
survey results’ ability to be applicable to a larger population size. The final important
limitation to the study is the possibility of differences in perception of what “mental
illness” is. Although a definition was given in the instructions of the CAMI scale,
answers for an individual may differ depending on the mental illness they have in mind.
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